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Reactive oxygen species (ROS) (i.e. hydroxyl
radicals, hydrogen peroxide and superoxide anion)
are formed during partial reduction of molecular
oxygen in the mitochondrial electron transport
chain. Presence of unpaired electron on the outer
orbitals of oxygen makes ROS highly toxic. Directly
or indirectly, damage of cellular constituents by
ROS contribute to various diseases such as inflam-
matory disorders, sarcomas, reperfusion injury after
revascularization of coronary artery as well as many
other disorders (1, 2).
In the defense against free radicals ROS are
neutralized by enzymatic and non-enzymatic antiox-
idant systems. Among antioxidative enzymes,
superoxide dismutase (SOD; EC 1.15.1.1) and cata-
lase (CAT; EC 1.11.1.6) play a key role. SOD con-
verts superoxide into highly toxic hydrogen perox-
ide, which in the presence of CAT is decomposed
into harmless water. In the non-enzymatic system,
macromolecules such as albumin or ceruloplasmin
and an array of small molecules, including ascorbic
acid, α-tocopherol, β-carotene, reduced glutathione
(GSH), uric acid, and bilirubin are involved (1, 2).
Antioxidant activity of biological fluid is a com-
bined effect of individual scavenging activity of
these antioxidants and may provide insight into the
overall prooxidantñantioxidant balance (3). 
Vita Glucan is a natural drug received by
extraction of Florida Oyster Mushrooms Pleurotus
ostreatus. The main component of Vita Glucan is
1,3-D-glucan known as pleuran (pleuran-β). 1,3-D-
glucans are water-soluble polysaccharides, whose
molecules have β-1,3 substituents in the main chain
and β-1,6 bonds in the branch points. This com-
pound is also synthesized by fungi strains of
Basidiomycetes. Other types of β-glucan isolated
from medicinal mushrooms are lentinan from
Shiitake mushroom (Lentinus edodes), schizophyl-
lan from Split gill fungus (Schizophyllum com-
mune), scleroglucan from Filamentous Fungi
(Sclerotium glucanicum), and grifolan from Maitke
mushroom (Grifola frondosa) (4). Vita Glucan is a
good source of essential amino acids, minerals (sele-
nium, magnesium, calcium, iron and zinc), folic acid
and vitamins of B group (B1, B2, B6), as well as
ascorbic acid and cholecalciferol. (5) 
A number of studies report that β-glucan plays
a beneficial role in prophylactic treatment of differ-
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ent types of bacterial or viral infections such as
influenza virus infection (6). It was also reported
that anti-antibodies of β-glucan can efficiently
immunize and protect against two major fungal
pathogens by mechanisms that may include direct
antifungal properties (7).
Recently, β-glucan has been postulated to
modulate antioxidant enzyme activity (SOD) as well
as to inhibit lipid peroxidation in different animal
studies: rats or rabbits (8-13). There are very few
reports on antioxidant effect of β-glucan in the
human blood (14).
The study was aimed to estimate influence of
Vita Glucan on SOD and CAT activities, as well as
on total antioxidant capacity (TAC) expressed as
total ferric reducing (antioxidant) activity and ascor-
bate concentration measurement (FRASC) in the
human blood, in vitro.
MATERIALS and METHODS
Vita Glucan was kindly provided by
Pharmaceutical Enterprise Apipol-Farma
(Myúlenice, Poland). Epinephrine solutions, pre-
pared for medical use, were obtained from Polish
Pharmaceutical Corporation Polfa - Warsaw.
Ascorbic acid, ascorbate oxidase and 2,4,6-
tripyridyltriazine (TPTZ) were purchased from
Sigma Aldrich. Other chemicals, such as acetate
buffer (pH= 3.6), FeSO4, and FeCl3 were of analyti-
cal grade, purchased in Industrial and Commercial
Company, Polish Chemical Reagents (Poland).
Study samples
Blood samples K3EDTA remaining after diag-
nostic tests ordered in frames of routine medical
checking were included in the present study. Only
samples of clinically healthy subjects (16 women
and 8 men) were used. Blood samples were divided
into the control and the study samples. 0.9 mL blood
of the control sample was incubated with 0.1 mL
150 mM/L NaCl, whereas 0.9 mL blood of the study
sample was incubated with 0.1 mL of preparation
Vita Glucan at concentrations 42.5; 85; 170; and
340 mg × 100 mL-1. After incubation for 30 min at
37OC the samples were centrifuged at 2000 × g for
15 min. The plasma was removed and red blood
cells were washed three times with sterile phosphate
buffered saline (PBS). Aliquots of plasma were used
for determination of FRASC values. Red blood cells
were hemolyzed in total volume of 3 mL of ice-cold
double-deionized water. Erythrocyte lysates were
used for measurement of antioxidant enzymes activ-
ities.  
Methods
CAT and SOD activities were determined
according to the Fridovichís and the Aebiís method,
respectively (15, 16). TAC, ferric reducing ability of
plasma (FRAP), and ascorbic acid (AA) were meas-
ured using a modified version of the FRAP assay,
known as FRASC. This method allows measure-
ment of reduced form of AA simultaneously with
the FRAP value (3). 
CAT assay
The method is based on the decline of hydro-
gen peroxide. 0.1 mL of samples was diluted with
2.9 mL 50 mM phosphate buffer (pH=7.0) and
mixed with 1 mL of hydrogen peroxide. Absorbance
was measured at λ = 240 nm immediately after addi-
tion of hydrogen peroxide to study samples (A0) and
after 15 s (A15). Assay reactions were performed at
25OC. CAT activity was calculated as follows: 
A0U = 0.153 . log ññññ
A15
SOD assay
The method is based on the SOD ability to
inhibit the epinephrine oxidation to adrenochrome.
Assay reactions were performed at 37O in air. 0.1 mL
of samples were diluted in 1.8 mL 50 mM carbohy-
drate buffer (pH = 10.2), mixed with 0.1 mL epi-
nephrine and 1 mL of 10 mM EDTA (pH = 10.2).
Absorbance was determined at λ = 480 nm immedi-
ately after addition of epinephrine and after 5 min.
SOD in the sample competes for superoxide, inhibit-
ing the epinephrine oxidation. The percentage of
inhibition was calculated as follows:
Acontrol ñ Asample%inhibition = ññññññññññññ × 100
Acontrol
One unit of SOD was defined as the amount of
enzyme that inhibits the oxidation by 50%. Blank
sample was used in order to exclude different spon-
taneous degrees of oxidation. The absorbance of
blank sample was subtracted from the absorbance of
the sample to calculate the real absorbance for each
sample.
TAC assay
The FRASC method is based on reduction of
Fe3+-TPTZ complex into Fe2+-TPTZ, which is visible
as blue, and the intensity of the color depends on the
concentration of AA. AA is selectively decomposed
by ascorbate oxidase. The absorbance is measured
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twice, directly after adding all components and 1
min. after (at λ=593 nm). The solution of AA should
be prepared directly before the assay due to its lia-
bility at room temperature. FRASC values were
obtained by comparing the absorbance of study sam-
ples at λ=593 nm with samples containing known
concentration of ascorbic acid and ferrous ions
(Fe2+). 
0.1 mL of sample was mixed with a 3 mL
reagent mixture, which included 2.8 mL of acetate
buffer (300 mM, pH = 3.6), a 0.17 mL TPTZ solu-
tion, and a 0.17 mL ferric (Fe3+) solution. The
reagents were warmed to 37OC. The calibration
graph was prepared using 5, 10, 20, 30, 40, 50, and
100 µM/L aqueous solution of AA. 
Statistical analysis
Differences between study and control samples
were analyzed by the U test of Mann-Whitney, using
STATISTICA v. 6.0 for Windows PL software
(Poland).
RESULTS
The results are presented in Figures 1-3. It was
found that Vita Glucan (VG) increased CAT and
Figure 2. Influence of Vita Glucan concentration on SOD activity in the human blood.
* See Figure 1.
Figure 1. Influence of Vita Glucan concentration on CAT activity in the human blood. 
* - Difference between study and control samples by the U test of Mann-Whitney significant at p ≤ 0.05. 
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SOD activities in erythrocytes hemolysates and the
FRASC value in plasma. CAT activity of red blood
cells hemolysates before incubation with β-glucan
was taken as 100% (Control).  
Increases of CAT activity ranged from 194%
for Vita Glucan at concentration of 170 mg × 100
mL-1 to 489% at concentration of 85 mg × 100 mL-1.
All changes of activity were statistically significant
(at p ≤ 0.05) (Figure 1). 
Incubation of hemolysates with Vita Glucan
resulted with a significantly higher activity of SOD
than obtained from the control samples (Figure 2).
The highest increase of SOD activity was observed
after addition of Vita Glucan to the incubation medi-
um at concentration of 85 mg × 100 mL-1, whereas the
lowest increase of SOD activity ñ though still statisti-
cally significant (at p ≤ 0.05) ñ was found after incu-
bation with concentrations of 170 mg × 100 mL-1.
The changes of FRASC after incubation of
blood with Vita Glucan at concentrations of 42.5 or
340 mg × 100 mL-1 were not statistically significant
(at p ≤ 0.05), however, the significance appeared at
concentrations of 170 or 85 mg × 100 mL-1 of this
medicine (Figure 3). 
DISCUSSION
In this study human blood samples were used
instead of ratsí or rabbitsí blood. Results of this
study have shown that pretreatment of blood sam-
ples with Vita Glucan at given concentration
increased markedly activities of antioxidant
enzymes in red blood cells hemolysates. 
Large variation of SOD activity and much
smaller variation of CAT activity may be due to dif-
ferent induction of the expression of the antioxidant
enzymes genes by the antioxidant (Vita Glucan).
Scandlios (8) suggested that antioxidant-specific
gene induction is mediated by the antioxidant
responsive element (ARE) commonly found in the
promoter region of genes. ARE was found in mam-
malian glutathione-S-transferase (GST), CAT and
SOD genes. In mammalian systems ARE was
reported to stimulate mitogen-activated protein
kinase (MAPK), which in turn triggers two classes
of transcription factors (nuclear factor kB and acti-
vator protein-1), leading to activation of antioxidant
defense genes. The degree to which a given gene is
activated depends on the cell type. 
The effects of another β-glucan (lentinan) on
SOD activity in human erythrocytes also have been
studied. Lentinan at higher concentration increased
the pathologically low SOD activity of erythrocytes
of patients with cirrhosis of the liver (5).
Similarly to our study, pleuran effect on CAT
and SOD has been reported (9). An increase in CAT
activity in erythrocytes and an increase in SOD activ-
ities in liver were observed. In another study, in a
model of acute colitis in rats, it was indicated that after
pleuran administration, within a month, antioxidant
defense (SOD activity) in erythrocytes was enhanced
(10). However, the same author did not observe
changes in antioxidant enzymes activities in blood of
rabbits which received Oyster mushroom diet (11).
Campa-Cordova et al. investigated whether β-
glucan induced immunostimulatory activity (12).
Figure 3. Influence of Vita Glucan concentration on FRASC value in the human blood.
* See Figure 1.
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The authors found that immunostimulation with β-
glucan was sufficient enough to generate an increase
in the antioxidant activity of L. vannamei SOD for
48-120 h.
As a conclusion, the results of the present study
support and confirm previous findings on antioxi-
dant properties of β-glucan extract in different ani-
mal studies. Another aspect of this study which
should be pointed out is that the most effective influ-
ence of Vita Glucan on antioxidant enzymes and
TAC was observed at the concentration of 85
mg × 100 mL-1 of preparation. It would therefore
appear reasonable to use Vita Glucan as an antioxi-
dant relevant in limiting diseases, particularly based
on impairment of oxidant/antioxidant balance.   
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